Nuveen Asset Management, LLC Ocular Therapeutix, Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 502,572 shares of OCUL stock, worth $4.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

502,572

Previous 416,773 20.59%

Holding current value

$4.99 Million

Previous $2.85 Million 53.4%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.45 - $9.23 $553,403 - $791,924	85,799 Added 20.59%	502,572 $4.37 Million
Q2 2024 Aug 09, 2024	SELL	$4.2 - $8.69 $3.35 Million - $6.92 Million	-796,672 Reduced 65.65%	416,773 $2.85 Million
Q1 2024 May 13, 2024	BUY	$3.85 - $10.93 $773,472 - $2.2 Million	200,902 Added 19.84%	1,213,445 $11 Million
Q4 2023 Feb 14, 2024	BUY	$2.08 - $4.52 $3,130 - $6,802	1,505 Added 0.15%	1,012,543 $4.52 Million
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $287,109 - $460,837	91,436 Added 9.94%	1,011,038 $3.17 Million
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $3.34 Million - $5.55 Million	726,569 Added 376.4%	919,602 $4.75 Million
Q1 2023 May 15, 2023	SELL	$2.79 - $6.27 $50,574 - $113,656	-18,127 Reduced 8.58%	193,033 $1.02 Million
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $120,326 - $203,309	-46,102 Reduced 17.92%	211,160 $594,000
Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $371,515 - $590,427	-90,835 Reduced 26.09%	257,262 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $61,036 - $105,851	20,278 Added 6.19%	348,097 $1.4 Million
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $298,151 - $453,708	-61,729 Reduced 15.85%	327,819 $1.67 Million
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $375,932 - $736,607	61,028 Added 18.58%	389,548 $2.42 Million
Q3 2021 Nov 12, 2021	BUY	$9.7 - $14.34 $657,776 - $972,424	67,812 Added 26.01%	328,520 $3.47 Million
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $77,316 - $110,304	5,757 Added 2.26%	260,708 $3.7 Million
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $5.47 Million - $7.64 Million	-345,720 Reduced 57.56%	254,951 $4.18 Million
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $2.8 Million - $8.12 Million	353,949 Added 143.46%	600,671 $12.4 Million
Q3 2020 Nov 16, 2020	BUY	$7.36 - $9.87 $209,671 - $281,176	28,488 Added 13.05%	246,722 $1.88 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $357,184 - $684,540	76,485 Added 53.96%	218,234 $1.82 Million
Q1 2020 May 14, 2020	BUY	$3.95 - $7.4 $32,630 - $61,131	8,261 Added 6.19%	141,749 $701,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $4.73 $149,941 - $275,962	-58,343 Reduced 30.41%	133,488 $527,000
Q3 2019 Nov 14, 2019	BUY	$3.04 - $5.32 $199,244 - $348,678	65,541 Added 51.9%	191,831 $583,000
Q2 2019 Aug 15, 2019	BUY	$2.46 - $4.52 $310,673 - $570,830	126,290 New	126,290 $556,000

Others Institutions Holding OCUL

# of Institutions

172

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $764M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Ocular Therapeutix, Inc Transaction History